Concentra Group Parent (CON) vs GRAIL (GRAL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Concentra Group Parent (CON) has outperformed GRAIL (GRAL) over the past year, gaining 106.8% versus a gain of 6.1%. Concentra Group Parent is the larger company by market cap ($5.26 billion vs $4.46 billion), about 1.2 times the size, while GRAIL is growing revenue faster (+17.2% vs +13.9%). Concentra Group Parent pays a dividend yielding 0.60%, while GRAIL does not currently pay one.
Concentra Group Parent converts more of its revenue into profit, with a net margin of 7.7% versus -277.5%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CON | GRAL |
|---|---|---|
| Share price | $41.84 | $99.25 |
| Market cap | $5.26B | $4.46B |
| 1-day change | +0.94% | -5.33% |
| YTD return | +112.60% | +15.96% |
| 1-year return | +106.82% | +6.09% |
| P/E ratio (TTM) | 24.76 | — |
| Forward P/E | 21.99 | — |
| EPS (TTM) | $1.69 | $-9.22 |
| Dividend yield | 0.60% | 0.00% |
| Annual dividend | $0.25 | $0.00 |
| Revenue (latest FY) | $2.16B | $147.17M |
| Revenue growth (YoY) | +13.85% | +17.18% |
| Net income (latest FY) | $166.41M | $-408.35M |
| Gross margin | 28.34% | — |
| Operating margin | 15.44% | -381.98% |
| Net margin | 7.69% | -277.47% |
| 52-week high | $44.22 | $166.48 |
| 52-week low | $19.05 | $41.50 |
| Distance from 52-week high | -5.38% | -40.38% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +11.62% | +40.49% |
| Average volume | 1.05M | 1.03M |
| Shares outstanding | 125.72M | 44.96M |
| Employees | 9,967 | 910 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CON has outperformed GRAL by 100.7 percentage points over the past year.
- Concentra Group Parent is more profitable, keeping 7.7 cents of every revenue dollar as net income versus -277.5 cents for GRAIL.
About Concentra Group Parent
CON stock →Concentra Group Holdings Parent, Inc. provides occupational health services in the United States.
Health Care · Medical Specialities · 9,967 employees
About GRAIL
GRAL stock →GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer.
Health Care · Medical Specialities · 910 employees
CON vs GRAL FAQ
Which is bigger, Concentra Group Parent or GRAIL?
Concentra Group Parent (CON) is larger, with a market capitalization of $5.26B compared with $4.46B for GRAIL (GRAL).
Which stock has performed better over the past year, CON or GRAL?
CON returned +106.82% over the past 12 months, compared with +6.09% for GRAL (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Concentra Group Parent or GRAIL?
Concentra Group Parent pays a dividend yielding 0.60%, while GRAIL does not currently pay a regular dividend.
Are Concentra Group Parent and GRAIL in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.